V29-1 The role of direct oral anticoagulants (DOACs) in hemodialysis
$15.00
Related products
-
V30-3 Medical use of cannabis for patients with end stage kidney disease
$15.00 Add to cart -
V29-4 Health Disparities and Outcomes in Canadian Indigenous End-Stage Kidney Disease Patients
$15.00 Add to cart -
V29-3 Potassium Binding Agents: Patiromer and Sodium Zirconium Cycloscilicate
$15.00 Add to cart -
V25-S1 Vascular Access Guidelines
$15.00 Add to cart